InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Sachs Jessica, Directeur Médical. Officer active across 1 companies, notably Cogent Biosciences, Inc.. In total, 3 disclosures have been logged. The latest transaction was filed on 30 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€4,390622 shares@ €7.05790.0001% mcap35.1% of flow
Common Stock
SEC:0000899243-22-024711:0·
€4,057674 shares@ €6.0194100.0% of flow
Common Stock
SEC:0000899243-22-000694·
€4,057674 shares@ €6.01940.0001% mcap32.4% of flow
Common Stock
SEC:0000899243-22-000694:0·
3 of 3 declarations
About Sachs Jessica
Jessica Sachs is the Chief Medical Officer at Cogent Biosciences, Inc. She is responsible for leading the company's medical and scientific initiatives. Her expertise in biotechnology and clinical research is essential for the development of new treatments. She plays a key role in guiding Cogent Biosciences' medical strategies.
